Clinical Trials
74 trialsNCT06901531 2026-06-05
LUCERNA
Astellas Pharma Inc
Phase 3 Recruiting
NCT05303532 2026-05-19
ROSY-D
AstraZeneca
Phase 3 Enrolling by invitation
NCT07583979 2026-05-13
EAST-ALIGN
National Cancer Centre, Singapore
Phase 3 Not yet recruiting
NCT05862285 2026-05-12
UmbrellaMAX
Hoffmann-La Roche
Phase 3 Recruiting
NCT03768063 2026-04-28
IMbrella B
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT04464226 2026-04-15
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Bayer
Phase 3 Active not recruiting
NCT03148418 2026-04-13
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT05377554 2026-04-13
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
Alume Biosciences, Inc.
Phase 3 Completed
NCT05112965 2026-04-06
An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT05629234 2026-04-06
ROSY-T
AstraZeneca
Phase 3 Active not recruiting
NCT06867705 2026-04-03
RC-102
Resilience
Phase 3 Recruiting
NCT01602380 2026-02-27
FALCON
AstraZeneca
Phase 3 Completed
NCT07270991 2026-02-05
FRUQUITAS
Federation Francophone de Cancerologie Digestive
Phase 3 Recruiting
NCT05053867 2026-01-14
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT07290491 2025-12-18
SPC
The Methodist Hospital Research Institute
Phase 3 Recruiting
NCT07287592 2025-12-17
Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.
Ain Shams University
Phase 3 Not yet recruiting
NCT05443737 2025-12-03
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
University of California, San Diego
Phase 3 Recruiting
NCT01579552 2025-11-12
Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Active not recruiting
NCT05454280 2025-07-08
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Fox Chase Cancer Center
Phase 3 Recruiting
NCT03578081 2025-04-06
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT03839940 2025-01-29
MIST
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT05872893 2023-07-21
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
Immune Oncology Research Institute
Phase 3 Unknown
NCT01968200 2023-06-28
ICOS-ONE
European Institute of Oncology
Phase 3 Unknown
NCT04763135 2023-06-08
MIR-P
Hospices Civils de Lyon
Phase 3 Terminated
NCT04613830 2023-02-03
Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients
Assiut University
Phase 3 Completed
NCT05551832 2022-10-25
Prevalence of Marginal Ulcer After PPPD and Preventive Effect of Proton Pump Inhibitor in Korea: A Prospective Multicenter Study
Gangnam Severance Hospital
Phase 3 Unknown
NCT03665441 2022-10-18
Trybeca-1
ERYtech Pharma
Phase 3 Completed
NCT00625378 2022-09-01
STEP
Bayer
Phase 3 Completed
NCT00305851 2022-07-15
Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Children's Oncology Group
Phase 3 Completed
NCT02454855 2022-06-13
MEQAPAG
Centre Jean Perrin
Phase 3 Terminated
NCT02625610 2022-06-09
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
EMD Serono
Phase 3 Completed
NCT00255138 2022-04-01
Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects
Temple University
Phase 3 Withdrawn
NCT01509612 2021-06-16
HIC
Medical University of Vienna
Phase 3 Completed
NCT02453334 2021-05-11
IRON CLAD
American Regent, Inc.
Phase 3 Completed
NCT02583932 2021-01-08
Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer
Jewish General Hospital
Phase 3 Completed
NCT02604225 2020-05-11
TRUSB
University of Sydney
Phase 3 Completed
NCT04292769 2020-03-03
Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors
Chinese PLA General Hospital
Phase 3 Unknown
NCT04217512 2020-01-03
Pantoprazole in Cisplatin Nephrotoxicity
Tanta University
Phase 3 Recruiting
NCT03961841 2019-12-23
Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Not yet recruiting
NCT00968968 2019-06-10
Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Novartis
Phase 3 Terminated
NCT03940053 2019-05-07
Prevention of Cancer Development and Progression
The First Affiliated Hospital of Zhengzhou University
Phase 3 Unknown
NCT02929693 2019-04-11
Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma
Shanghai University of Traditional Chinese Medicine
Phase 3 Unknown
NCT00405522 2019-03-08
Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children
The Hospital for Sick Children
Phase 3 Completed
NCT01479192 2018-11-07
Fenretinide in Healthy Young Women at Genetic and Familial Risk
European Institute of Oncology
Phase 3 Terminated
NCT00199602 2018-08-24
Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients
University Hospital, Limoges
Phase 3 Completed
NCT01032512 2018-02-19
Clinical Benefits of Preoperative Nutrition Support With Enteral Immune-enhancing Formulas in Surgical Oncology
University of Chile
Phase 3 Withdrawn
NCT00380406 2017-04-05
PROOF
Ottawa Hospital Research Institute
Phase 3 Completed
NCT02721641 2017-03-31
A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT01858571 2017-01-25
Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric Malignancies
All India Institute of Medical Sciences
Phase 3 Completed
NCT00565188 2016-10-25
Application of ATP Infusions in Palliative Home Care
Maastricht University Medical Center
Phase 3 Completed